The Cooper Companies, Inc. (NYSE:COO) Shares Sold by CIBC Asset Management Inc

CIBC Asset Management Inc lessened its holdings in The Cooper Companies, Inc. (NYSE:COOGet Rating) by 16.3% during the 1st quarter, HoldingsChannel.com reports. The firm owned 9,377 shares of the medical device company’s stock after selling 1,831 shares during the period. CIBC Asset Management Inc’s holdings in Cooper Companies were worth $3,916,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. BlackRock Inc. lifted its stake in Cooper Companies by 4.1% during the 4th quarter. BlackRock Inc. now owns 4,000,869 shares of the medical device company’s stock worth $1,676,126,000 after acquiring an additional 158,358 shares in the last quarter. State Street Corp lifted its stake in Cooper Companies by 2.3% during the 4th quarter. State Street Corp now owns 2,167,499 shares of the medical device company’s stock worth $908,052,000 after acquiring an additional 49,729 shares in the last quarter. Veritas Asset Management LLP lifted its stake in Cooper Companies by 12.0% during the 4th quarter. Veritas Asset Management LLP now owns 2,001,678 shares of the medical device company’s stock worth $838,583,000 after acquiring an additional 214,700 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC lifted its stake in Cooper Companies by 5.5% during the 4th quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,168,375 shares of the medical device company’s stock worth $489,479,000 after acquiring an additional 61,222 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its stake in Cooper Companies by 1.1% during the 4th quarter. JPMorgan Chase & Co. now owns 954,397 shares of the medical device company’s stock worth $399,832,000 after acquiring an additional 9,956 shares in the last quarter. Institutional investors and hedge funds own 98.38% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Robert W. Baird decreased their target price on Cooper Companies from $437.00 to $392.00 in a research note on Thursday, May 26th. Stephens reduced their price target on Cooper Companies from $500.00 to $460.00 and set an “overweight” rating on the stock in a research report on Friday, June 3rd. Citigroup increased their price target on Cooper Companies from $405.00 to $406.00 and gave the company a “buy” rating in a research report on Monday, June 6th. Wells Fargo & Company reduced their price target on Cooper Companies from $495.00 to $380.00 and set an “overweight” rating on the stock in a research report on Monday, May 23rd. Finally, Piper Sandler reduced their price target on Cooper Companies from $425.00 to $375.00 and set an “overweight” rating on the stock in a research report on Friday, July 8th. Three analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $426.78.

Cooper Companies Trading Up 1.1 %

COO opened at $330.91 on Friday. The Cooper Companies, Inc. has a one year low of $284.01 and a one year high of $463.59. The company has a market cap of $16.33 billion, a P/E ratio of 17.38, a PEG ratio of 2.49 and a beta of 0.90. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.69 and a current ratio of 1.05. The business’s 50-day simple moving average is $319.08 and its 200-day simple moving average is $363.62.

Cooper Companies (NYSE:COOGet Rating) last released its quarterly earnings data on Thursday, June 2nd. The medical device company reported $3.24 EPS for the quarter, missing analysts’ consensus estimates of $3.41 by ($0.17). Cooper Companies had a net margin of 30.20% and a return on equity of 9.48%. The business had revenue of $829.80 million during the quarter, compared to analysts’ expectations of $821.03 million. During the same quarter in the previous year, the company posted $3.38 EPS. The company’s revenue was up 15.3% compared to the same quarter last year. As a group, equities research analysts expect that The Cooper Companies, Inc. will post 13.17 EPS for the current fiscal year.

Cooper Companies Dividend Announcement

The company also recently declared a semi-annual dividend, which will be paid on Thursday, August 11th. Investors of record on Wednesday, July 27th will be paid a dividend of $0.03 per share. The ex-dividend date is Tuesday, July 26th. Cooper Companies’s dividend payout ratio is presently 0.32%.

Cooper Companies Company Profile

(Get Rating)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Read More

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NYSE:COOGet Rating).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.